| 臺大學術典藏 |
2022-09-15T01:09:04Z |
Nuclear factor-κB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Chiang Y.; Wang C.-C.; Tsai Y.-C.; Huang C.-Y.; Pu Y.-S.; Chia-Chi Lin; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:04Z |
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
|
Shaw A.T.; Solomon B.J.; Chiari R.; Riely G.J.; Besse B.; Soo R.A.; Kao S.; Chia-Chi Lin; Bauer T.M.; Clancy J.S.; Thurm H.; Martini J.-F.; Peltz G.; Abbattista A.; Li S.; Ou S.-H.I. |
| 臺大學術典藏 |
2022-09-15T01:09:05Z |
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study
|
Ma W.-L.; Chia-Chi Lin; Hsu F.-M.; Lee J.-M.; Chen J.-S.; Hsieh M.-S.; Chang Y.-L.; Chao Y.-T.; Chang C.-H.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2022-09-15T01:09:06Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:51Z |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Chia-Chi Lin; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:51Z |
Down-regulated expression of RhoA in human conventional renal cell carcinoma
|
Pu Y.-S.; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; Huang C.-Y.; Kang W.-Y.; Shun C.-T.; Chia-Chi Lin; Wu W.-J.; Hour T.-C. |
| 臺大學術典藏 |
2022-09-15T01:09:51Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.; Chia-Chi Lin; Lee J.-M.; Chang Y.-L.; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Chia-Chi Lin; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J. |
| 臺大學術典藏 |
2022-09-15T01:09:53Z |
Novel targeted therapies for advanced esophageal cancer
|
Chia-Chi Lin; Papadopoulos K.P. |
